Abbott Laboratories

NYSE: ABT · Real-Time Price · USD
133.73
0.77 (0.58%)
At close: Jun 05, 2025, 3:59 PM
134.62
0.67%
Pre-market: Jun 06, 2025, 04:10 AM EDT

Abbott Laboratories Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Diagnostic Products Revenue 9.34B 9.99B 16.58B 15.64B 10.8B 7.71B 7.5B 5.62B 4.81B 4.65B 4.72B 4.54B 4.29B 4.13B
Diagnostic Products Revenue Growth -6.48% -39.77% +6.01% +44.78% +40.09% +2.91% +33.46% +16.68% +3.59% -1.59% +3.87% +5.89% +4.02% n/a
Established Pharmaceutical Products Revenue 5.19B 5.07B 4.91B 4.72B 4.3B 4.49B 4.42B 4.29B 3.86B 3.72B 3.12B 4.97B 23.13B 22.43B
Established Pharmaceutical Products Revenue Growth +2.53% +3.14% +4.11% +9.64% -4.08% +1.45% +3.15% +11.09% +3.74% +19.31% -37.31% -78.50% +3.11% n/a
Medical Devices Revenue 18.99B 16.89B 14.69B 14.37B 11.79B 12.24B 7.23B 6.92B 6.9B 6.97B 6.95B 6.74B 6.47B 6.01B
Medical Devices Revenue Growth +12.43% +14.98% +2.23% +21.89% -3.69% +69.30% +4.39% +0.38% -1.09% +0.32% +3.16% +4.16% +7.74% n/a
Nutritional Products Revenue 8.41B 8.15B 7.46B 8.29B 7.65B 7.41B n/a n/a n/a n/a n/a n/a n/a n/a
Nutritional Products Revenue Growth +3.18% +9.32% -10.07% +8.46% +3.21% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Non-Us Revenue 25.63B 24.66B 25.51B 26.43B 21.59B 20.51B 19.74B 17.72B 14.37B 14.13B 14.12B 15.58B 23.09B 22.84B 19.97B
Non-Us Revenue Growth +3.93% -3.35% -3.49% +22.45% +5.27% +3.89% +11.41% +23.32% +1.64% +0.08% -9.34% -32.53% +1.11% +14.34% n/a
United States Revenue 16.32B 15.45B 18.14B n/a 13.02B n/a n/a 9.67B 6.49B 6.27B 6.12B 6.27B 16.78B 16.01B 15.19B
United States Revenue Growth +5.64% -14.83% n/a n/a n/a n/a n/a +49.14% +3.44% +2.40% -2.33% -62.65% +4.81% +5.40% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 3.06B 2.91B 2.9B 2.92B 2.94B 2.7B 2.6B 2.62B 2.62B 2.97B 2.73B 2.76B 2.79B 3.05B 2.77B 2.73B 2.78B 2.57B 2.3B 2.28B 2.55B 2.41B 2.44B 2.43B 2.48B 2.36B 2.38B 2.47B 2.54B 2.46B 2.1B 2.13B 2.42B 1.61B 1.63B 1.74B 1.7B 1.66B 1.67B 1.73B 1.74B
Selling, General, and Administrative Revenue Growth +5.30% +0.41% -0.69% -0.95% +8.84% +3.96% -0.69% +0.15% -12.04% +8.86% -0.94% -1.08% -8.56% +10.16% +1.50% -2.05% +8.29% +11.64% +1.14% -10.68% +5.59% -1.11% +0.25% -1.78% +5.04% -0.76% -3.61% -2.99% +3.25% +17.29% -1.55% -12.05% +50.65% -1.17% -6.28% +2.30% +2.60% -0.66% -3.53% -0.58% n/a
Research and Development Revenue 716M 754M 713M 698M 679M 690M 672M 715M 654M 725M 782M 684M 697M 762M 672M 654M 654M 698M 580M 564M 578M 595M 596M 577M 672M 562M 574M 575M 589M 613M 562M 513M 547M 343M 352M 348M 379M 369M 378M 345M 313M
Research and Development Revenue Growth -5.04% +5.75% +2.15% +2.80% -1.59% +2.68% -6.01% +9.33% -9.79% -7.29% +14.33% -1.87% -8.53% +13.39% +2.75% 0.00% -6.30% +20.34% +2.84% -2.42% -2.86% -0.17% +3.29% -14.14% +19.57% -2.09% -0.17% -2.38% -3.92% +9.07% +9.55% -6.22% +59.48% -2.56% +1.15% -8.18% +2.71% -2.38% +9.57% +10.22% n/a